432 related articles for article (PubMed ID: 33949933)
1. Rediscovering Potential Molecular Targets for Glioma Therapy Through the Analysis of the Cell of Origin, Microenvironment and Metabolism.
Guo X; Wang T; Huang G; Li R; Da Costa C; Li H; Lv S; Li N
Curr Cancer Drug Targets; 2021; 21(7):558-574. PubMed ID: 33949933
[TBL] [Abstract][Full Text] [Related]
2. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
3. The Oncogenesis of Glial Cells in Diffuse Gliomas and Clinical Opportunities.
Zhuang Q; Yang H; Mao Y
Neurosci Bull; 2023 Mar; 39(3):393-408. PubMed ID: 36229714
[TBL] [Abstract][Full Text] [Related]
4. Cancer Metabolism: The Role of Immune Cells Epigenetic Alteration in Tumorigenesis, Progression, and Metastasis of Glioma.
Kanwore K; Kanwore K; Adzika GK; Abiola AA; Guo X; Kambey PA; Xia Y; Gao D
Front Immunol; 2022; 13():831636. PubMed ID: 35392088
[TBL] [Abstract][Full Text] [Related]
5. Targeting of endoplasmic reticulum (ER) stress in gliomas.
Markouli M; Strepkos D; Papavassiliou AG; Piperi C
Pharmacol Res; 2020 Jul; 157():104823. PubMed ID: 32305494
[TBL] [Abstract][Full Text] [Related]
6. Immune Checkpoint Inhibitors in Human Glioma Microenvironment.
Ghouzlani A; Kandoussi S; Tall M; Reddy KP; Rafii S; Badou A
Front Immunol; 2021; 12():679425. PubMed ID: 34305910
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory Effects of Tryptophan Metabolism in the Glioma Tumor Microenvironment.
Xu Y; Zhang H; Sun Q; Geng R; Yuan F; Liu B; Chen Q
Front Immunol; 2021; 12():730289. PubMed ID: 34659216
[TBL] [Abstract][Full Text] [Related]
8. Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma.
Ma Q; Long W; Xing C; Chu J; Luo M; Wang HY; Liu Q; Wang RF
Front Immunol; 2018; 9():2924. PubMed ID: 30619286
[TBL] [Abstract][Full Text] [Related]
9. Role of the Microenvironment in Glioma Pathogenesis.
Jayaram MA; Phillips JJ
Annu Rev Pathol; 2024 Jan; 19():181-201. PubMed ID: 37832944
[TBL] [Abstract][Full Text] [Related]
10. Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment.
Hatipoglu G; Hock SW; Weiss R; Fan Z; Sehm T; Ghoochani A; Buchfelder M; Savaskan NE; Eyüpoglu IY
Cancer Sci; 2015 Feb; 106(2):160-70. PubMed ID: 25458015
[TBL] [Abstract][Full Text] [Related]
11. The Role of BEHAB/Brevican in the Tumor Microenvironment: Mediating Glioma Cell Invasion and Motility.
Giamanco KA; Matthews RT
Adv Exp Med Biol; 2020; 1272():117-132. PubMed ID: 32845505
[TBL] [Abstract][Full Text] [Related]
12. Metabolic regulation of glioma stem-like cells in the tumor micro-environment.
Thomas TM; Yu JS
Cancer Lett; 2017 Nov; 408():174-181. PubMed ID: 28743531
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.
Poff A; Koutnik AP; Egan KM; Sahebjam S; D'Agostino D; Kumar NB
Semin Cancer Biol; 2019 Jun; 56():135-148. PubMed ID: 29294371
[TBL] [Abstract][Full Text] [Related]
14. Identification of PIEZO1 as a potential prognostic marker in gliomas.
Zhou W; Liu X; van Wijnbergen JWM; Yuan L; Liu Y; Zhang C; Jia W
Sci Rep; 2020 Sep; 10(1):16121. PubMed ID: 32999349
[TBL] [Abstract][Full Text] [Related]
15. Glial progenitors as targets for transformation in glioma.
Ilkhanizadeh S; Lau J; Huang M; Foster DJ; Wong R; Frantz A; Wang S; Weiss WA; Persson AI
Adv Cancer Res; 2014; 121():1-65. PubMed ID: 24889528
[TBL] [Abstract][Full Text] [Related]
16. Role of Exosomes in the Progression, Diagnosis, and Treatment of Gliomas.
Shi J; Zhang Y; Yao B; Sun P; Hao Y; Piao H; Zhao X
Med Sci Monit; 2020 Nov; 26():e924023. PubMed ID: 33245712
[TBL] [Abstract][Full Text] [Related]
17. Integration of clinical and spatial data to explore lipid metabolism-related genes for predicting prognosis and immune microenvironment in gliomas.
Yu Z; Zhou Y; Li Y; Dong Z
Funct Integr Genomics; 2023 Mar; 23(2):82. PubMed ID: 36929451
[TBL] [Abstract][Full Text] [Related]
18. The CXCL Family Contributes to Immunosuppressive Microenvironment in Gliomas and Assists in Gliomas Chemotherapy.
Wang Z; Liu Y; Mo Y; Zhang H; Dai Z; Zhang X; Ye W; Cao H; Liu Z; Cheng Q
Front Immunol; 2021; 12():731751. PubMed ID: 34603309
[TBL] [Abstract][Full Text] [Related]
19. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
Zhao WJ; Ou GY; Lin WW
Front Immunol; 2021; 12():682415. PubMed ID: 34054873
[TBL] [Abstract][Full Text] [Related]
20. Emerging Approaches for Targeting Metabolic Vulnerabilities in Malignant Glioma.
Clark PM; Mai WX; Cloughesy TF; Nathanson DA
Curr Neurol Neurosci Rep; 2016 Feb; 16(2):17. PubMed ID: 26759318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
